KDM2A and neoplasm: Analysis of tumor growth revealed that inactivation of KDM2A by sgK#1 or sgK#2 significantly inhibited the in vivo tumorigenicity (Fig. 1l, m), indicating that KDM2A is required for ALT-driven tumor propagation.